Interpretation of Novel Coronavirus Infection :Expert Consensus on Guidance and Prevention Strategies for Hospi tal Pharmacists and the Pharmacy Workforce
- VernacularTitle:《新型冠状病毒感染:医院药学工作指导与防控策略专家共识》解读
- Author:
Rongsheng ZHAO
1
;
Yiheng YANG
1
;
Li YANG
1
;
Zijian LI
1
;
Fang LIU
1
;
Zhenyu REN
1
;
Wei LIU
1
;
Zhanmiao YI
1
;
Yingqiu YING
1
;
Xiaoxiao LI
1
;
Yingying YAN
1
;
Huibo LI
1
;
Shujie DONG
1
;
Weilong SHI
1
;
Xiaohan XU
1
;
Pengxiang ZHOU
1
;
Zaiwei SONG
1
;
Siqian ZHENG
1
;
Ying LIU
1
;
Shen ZHOU
1
;
Suodi ZHAI
1
Author Information
- Publication Type:Journal Article
- Keywords: Coronavirus; SARS-CoV-2; Hospital pharmacy; Work guidance; Prevention strategies; Interpretation
- From: China Pharmacy 2020;31(4):385-389
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE:To provid e reference for pharmaceutical workers to better understand Novel Coronavirus Infection : Expert Consensus on Guidance and Prevention Strategies for Hospital Pharmacists and the Pharmacy Workforce (hereinafter referred to as “expert consensus ”),and to apply and practice in specific work ,so as to give full play to the role of pharmacists to help fight the epidemic.METHODS :The background of the formulation and revision of the expert consensus were introduced ,and its main contents and viewpoints were interpreted. RESULTS & CONCLUSIONS :The text of expert consensus is divided into 8 parts,mainly including disease diagnosis and treatment [SARS-CoV- 2 infection related background ,clinical manifestations and diagnosis, treatment],hospital pharmacy (prevention and control strategy ,work guidance ),drug and facility support management(key drug/facility/equipment support ,management and use of the drug in special circumstances ),information sources and related resources ,etc.,which comprehensively and detailedly provide information ,guidance and strategies for coronavirus SARS-CoV-2 infection prevention and control to play the role of pharmacists in hospital pharmacy well ,do well in the protection of staff in different pharmaceutical posts ,drug security work in response to epidemic situation ,and develop pharmaceutical care. So far,the understanding of SARS-CoV- 2 in the pharmaceutical industry is relatively limited. Based on the accumulated experience and progress in epidemic prevention and control ,the expert consensus will be updated and improved continuously ,so as to provide guidance and help for hospital pharmaceutical personnel.